Exchange Traded Concepts Trims Illumina Stock Holdings

Asset management firm reduces position in life sciences company by 10.8% in Q4 2025

Mar. 28, 2026 at 8:36am

Got story updates? Submit your updates here. ›

Exchange Traded Concepts LLC, an investment management firm, lowered its position in shares of Illumina, Inc. (NASDAQ:ILMN) by 10.8% in the fourth quarter of 2025, according to the company's latest 13F filing with the Securities and Exchange Commission. The fund now owns 195,389 shares of the life sciences company's stock, worth approximately $25.6 million.

Why it matters

Illumina is a leading provider of DNA sequencing systems and related products, serving the life sciences industry. Changes in institutional ownership of the company's stock can signal shifts in market sentiment and investment trends within the genomics and biotechnology sectors.

The details

Exchange Traded Concepts sold 23,622 shares of Illumina during the fourth quarter, reducing its total position to 195,389 shares. The firm now owns approximately 0.13% of Illumina's outstanding stock. Several other institutional investors have also recently modified their holdings of Illumina, with some increasing and others decreasing their positions in the company.

  • Exchange Traded Concepts filed its 13F report for the fourth quarter of 2025 on March 28, 2026.
  • The firm's position change occurred during the three-month period from October 1 to December 31, 2025.

The players

Exchange Traded Concepts LLC

An investment management firm that provides exchange-traded fund (ETF) products and services.

Illumina, Inc.

A leading provider of DNA sequencing systems and related products for the life sciences industry.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Exchange Traded Concepts' Illumina holdings reflects the broader volatility and uncertainty surrounding the genomics industry, as investors navigate regulatory changes, technological advancements, and evolving market dynamics.